| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 246 |
| 1 | ASPIRIN | 108 |
| 2 | ASPIRIN 325 MG | 53 |
| 3 | ASPIRIN 81 MG | 53 |
| 4 | ASPIRIN TABLET 325MG | 53 |
| 5 | CLOPIDOGREL | 46 |
| 6 | FUROSEMIDE | 34 |
| 7 | PANTOPRAZOLE | 24 |
| 8 | CLOPIDOGREL BISULFATE | 23 |
| 9 | APIXABAN | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 2 | 0.0220 |
| 1 | BAYER ASPIRIN EXTRA STRENGTH | 9 | 0.0025 |
| 2 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0022 |
| 3 | AMISH ORIGINS MEDICATED | 1 | 0.0017 |
| 4 | COUGH SUPPRESSANT | 1 | 0.0017 |
| 5 | BRIGATINIB | 3 | 0.0015 |
| 6 | RIVAROXABAN | 246 | 0.0014 |
| 7 | IRON SUCROSE | 9 | 0.0014 |
| 8 | DARIFENACIN HYDROBROMIDE | 1 | 0.0014 |
| 9 | CAPLACIZUMAB | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 262 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 142 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 130 |
| 3 | Loop Diuretic [EPC] | 35 |
| 4 | beta-Adrenergic Blocker [EPC] | 23 |
| 5 | Calcium Channel Blocker [EPC] | 15 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 15 |
| 7 | Proton Pump Inhibitor [EPC] | 15 |
| 8 | Aldosterone Antagonist [EPC] | 14 |
| 9 | Benzodiazepine [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Parenteral Iron Replacement [EPC] | 9 | 0.0009 |
| 1 | Factor Xa Inhibitor [EPC] | 262 | 0.0007 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0004 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0003 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 130 | 0.0003 |
| 5 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 6 | Anti-anginal [EPC] | 4 | 0.0002 |
| 7 | alpha-Adrenergic Blocker [EPC] | 14 | 0.0002 |
| 8 | Anticholinergic [EPC] | 2 | 0.0002 |
| 9 | Loop Diuretic [EPC] | 35 | 0.0002 |